Search

everythinglearnresearchcommunity

for

Search:↓

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Male pattern baldness is largely genetic, linked to the androgen receptor gene, and may relate to certain health issues.

People with primary cicatricial alopecia have a higher risk of heart disease and stroke.

Oral testosterone therapy raises heart risk more than other methods.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

People with androgenetic alopecia may have a higher genetic risk for cardiovascular diseases.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Finasteride may increase stroke risk in people with clotting tendencies.

Higher cholesterol levels increase aggressive prostate cancer risk.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Women with AGA have higher lipid levels, increasing heart disease risk.

Patients with early-onset androgenetic alopecia have a higher risk of metabolic syndrome and carotid arteriosclerosis, suggesting the need for early cardiovascular screening and prevention.

Unhealthy diet and lifestyle choices may increase the risk of hair loss in women.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Early male hair loss might signal higher heart disease risk.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Early hair loss may indicate a higher risk of diabetes in young and middle-aged adults.